Ticker Details
PTC Therapeutics, Inc. PTC Therapeutics Inc is a biopharmaceutical company. It is focused on the discovery and development of orally administered, proprietary small-molecule drugs that target post-transcriptional control processes.
IPO Date:	June 20, 2013
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$7.43B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.97 | 2.85%
Avg Daily Range (30 D):	$1.49 | 1.98%
Avg Daily Range (90 D):	$1.35 | 1.91%

Institutional Daily Volume
Avg Daily Volume:	.74M
Avg Daily Volume (30 D):	1.57M
Avg Daily Volume (90 D):	1.11M

Trade Size
Avg Trade Size (Sh.):	86
Avg Trade Size (Sh.) (30 D):	70
Avg Trade Size (Sh.) (90 D):	60

Institutional Trades
Total Institutional Trades:	8,301
Avg Institutional Trade:	$3.09M
Avg Institutional Trade (30 D):	$6.4M
Avg Institutional Trade (90 D):	$6.52M
Avg Institutional Trade Volume:	.07M
Avg Institutional Trades (Per Day):	3

Market Closing Trades
Avg Closing Trade:	$5.42M
Avg Closing Trade (30 D):	$32.44M
Avg Closing Trade (90 D):	$22.19M
Avg Closing Volume:	118.18K

News

Dec 31, 2025 @ 3:47 PM What's Going On With Royalty Pharma Stock Wednesda... Source: Vandana Singh

Dec 29, 2025 @ 9:40 PM Royalty Pharma Acquires Remaining Royalty Interest... Source: Globe Newswire

Sep 5, 2025 @ 12:35 PM Here's Why Shares in PTC Therapeutics Soared This ... Source: Lee Samaha

Jul 17, 2025 @ 5:00 AM Novartis reports strong Q2 with double-digit sales... Source: Novartis

Jun 2, 2025 @ 5:55 PM INVESTOR ALERT: Pomerantz Law Firm Investigates Cl... Source: N/A

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-2.48	$-.03	$-1.82
Diluted EPS	$-2.33	$-.03	$-1.67
Revenue	$827.11M	$272.55M	$164.68M
Gross Profit
Net Income / Loss	$-186.73M	$-2.81M	$-134.97M
Operating Income / Loss	$-58.33M	$44.96M	$-71.35M
Cost of Revenue
Net Cash Flow	$-661.22M	$-146.38M	$302.24M
PE Ratio